Company profile: ProtaGene
1.1 - Company Overview
Company description
- Provider of analytic services for biopharmaceutical, cell, and gene therapy development, delivering complete protein and gene analytics and product testing. Offerings include product characterization and attribute analysis, method development, GMP testing, QC lot release and stability methods, candidate evaluation and optimization, IND selection, and commercial-stage comparability testing.
Products and services
- Biologic Drug Analytics: Delivers GMP-compliant method development, early-to-late stage characterization, GMP product testing, and full analytical packages supporting biologic therapeutics’ product lifecycle management
- Manufacturing and QC: Supplies regulatory-grade analytical services from discovery to market, including biologic candidate evaluation, optimization, selection into IND, and commercial-stage comparability testing using qualified advanced methods
- Product Characterization & Attribute Analysis: Offers multi-tier characterization encompassing primary, secondary, and higher order structural assessment, biological activity assessment, and analysis of product and process impurities.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ProtaGene
Celerion
HQ: United States
Website
- Description: Provider of early clinical research and Applied Translational Medicine, translating research discoveries into knowledge of drug action in humans to support early development decisions. Services include bioanalytical sciences for small and large molecules; clinical development (safety, PK/PD); data management and biometrics; global drug development (regulatory, project management); EDC; and eTMF via secure, DIA-formatted portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celerion company profile →
Apex Innovative Sciences
HQ: United States
Website
- Description: Provider of independent clinical trial site operations focused on central nervous system indications and other therapeutic areas, including neurology, psychiatry, and addiction, delivering high scientific and clinical quality for client partners and participants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apex Innovative Sciences company profile →
Noramco
HQ: United States
Website
- Description: Provider of design, construction, and management services for bulk active pharmaceutical ingredient plants, including a Wilmington, Delaware facility supporting Ortho-McNeil Pharmaceutical's Tylenol with codeine business; expanded through the acquisition of Tasmanian Alkaloids and the addition of an Athens, Georgia site in 1982.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noramco company profile →
Alliance Pharma
HQ: United Kingdom
Website
- Description: Provider of healthcare solutions through the acquisition and licensing of mature pharmaceutical products, with manufacturing, storage, logistics, and sales operations controlled by Alliance and outsourced to leading specialist organisations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alliance Pharma company profile →
PolyPeptide
HQ: Switzerland
Website
- Description: Provider of contract manufacturing for peptides and peptide-related molecules with a global presence ensuring reliable supply. One of the world's largest independent contract manufacturers of therapeutic peptides, offering peptide and oligonucleotide API development and manufacturing, generic and cosmetic peptides, and green chemistry initiatives, including a production-scale solvent recovery system with Donaldson Company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PolyPeptide company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ProtaGene
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ProtaGene
2.2 - Growth funds investing in similar companies to ProtaGene
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ProtaGene
4.2 - Public trading comparable groups for ProtaGene
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →